XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.66

+2.8%

Jan 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (8739)	2/16/1999 7:42:00 AM
From: Robert K.	Read Replies (3) of 17367

If bpi21 can just get to market then everything else will start to fall into place.........IMO "we study the place of the p15s in antimicrobial and inflammatory host defense, including their ability to dramatically increase BPI potency." > Ditto that for LBP which also happens to be highest in the disease states they are persuing. Meningo as a example. All disclaimers, all IMO

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next